Sarah Jackson

Dr. Sarah Jackson is a Principal Research Fellow in the Department of Behavioural Science and Health at University College London (UCL). She leads the UCL Alcohol and Tobacco Research Group, focusing on population-level analysis of smoking, vaping, and alcohol consumption patterns. Her research evaluates cessation interventions using large-scale datasets like the Smoking and Alcohol Toolkit Study.

Education includes a doctorate from UCL (2014), MSc from Roehampton University (2010), and BSc from University of Sussex (2009). She holds professional certifications as a Chartered Psychologist and HEA Fellow.

Research interests center on:

• Longitudinal trends in substance use behaviors
• Effectiveness of public health policies and cessation aids
• Socioeconomic determinants of smoking/vaping disparities
• Impact of regulatory changes on population health outcomes

Her 180+ publications primarily analyze nicotine product usage patterns, cessation intervention efficacy, and behavioral responses to public health policies. Recent work examines COVID-19 impacts on substance use and emerging vaping trends among youth and non-smokers.

Awards and recognition:

• Society for the Study of Addiction Impact Prize
• Fred Yates Early Career Award
• UK Society for Behavioural Medicine Early Career Award

Leadership roles include:

• President of SRNT Europe
• Senior Editor at Addiction journal
• Advisor to Action on Smoking and Health

She teaches the Health-Related Behaviours and Cognitions module for UCL's MSc Health Psychology program and supervises graduate students.